FOUNTAIN VALLEY, CALIFORNIA--(MARKET WIRE)--Jul 23, 2007 -- Sutura, Inc. (“Sutura”) (OTC BB:SUTU.OB - News), an innovative developer of minimally invasive vascular suturing devices, today announced the appointment of Dr. Michael Mullen to its Clinical Advisory Board. Dr. Mullen is currently consultant cardiologist and Director of the Cath Lab at Royal Brompton Hospital in London, specializing in adult congenital interventional catheter laboratory procedures.
